AMG 334 CGRP antibody for migraine: time to celebrate?

被引：8
|
作者：
Ramos, Marta L. [1 ,2 ]
Pascual, Julio [3 ,4 ]
机构：
[1] Hosp Occidente Kennedy, Dept Neurol, Bogota, Colombia
[2] Univ La Sabana, Bogota, Colombia
[3] Univ Hosp Marques Valdecilla, Santander 39008, Spain
[4] IDIVAL, Santander 39008, Spain
来源：
LANCET NEUROLOGY | 2016年 / 15卷 / 04期
关键词：
GENE-RELATED PEPTIDE; DOUBLE-BLIND; PREVENTIVE TREATMENT; EPISODIC MIGRAINE; PHASE; 2B; EFFICACY; SAFETY; TOLERABILITY; CIRCULATION; MULTICENTER;
D O I：
10.1016/S1474-4422(16)00040-5
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：347 / 349
页数：4
相关论文
共 50 条
  • [31] Effectiveness of switching strategies in CGRP monoclonal antibody therapy for migraine: A retrospective cohort study
    Jaimes, Alex
    Gomez, Andrea
    Pajares, Olga
    Rodriguez-Vico, Jaime
    HEADACHE, 2024,
  • [32] TEV-48125: a Review of a Monoclonal CGRP Antibody in Development for the Preventive Treatment of Migraine
    Sarah Walter
    Marcelo E. Bigal
    Current Pain and Headache Reports, 2015, 19
  • [33] TEV-48125: a Review of a Monoclonal CGRP Antibody in Development for the Preventive Treatment of Migraine
    Walter, Sarah
    Bigal, Marcelo E.
    CURRENT PAIN AND HEADACHE REPORTS, 2015, 19 (03)
  • [34] The combination of a CGRP monoclonal antibody and a small molecule CGRP antagonist for treatment of migraine is well tolerated and effective compared to standard of care
    Murtha, J. K.
    Tolebeyan, A.
    Partovi, O.
    Sivakumar, D.
    Freitag, F. G.
    HEADACHE, 2022, 62 : 166 - 167
  • [35] CGRP receptor antagonism and migraine
    Lars Edvinsson
    Tony W. Ho
    Neurotherapeutics, 2010, 7 : 164 - 175
  • [36] CGRP Antibodies as Prophylaxis in Migraine
    Edvinsson, Lars
    CELL, 2018, 175 (07) : 1719 - 1719
  • [37] Safety and efficacy of AMG 334 for prevention of episodic migraine: a randomised, double-blind, placebo-controlled, phase 2 trial
    Sun, Hong
    Dodick, David W.
    Silberstein, Stephen
    Goadsby, Peter J.
    Reuter, Uwe
    Ashina, Messoud
    Saper, Joel
    Cady, Roger
    Chon, Yun
    Dietrich, Julie
    Lenz, Robert
    LANCET NEUROLOGY, 2016, 15 (04): : 382 - 390
  • [38] Gender aspects of CGRP in migraine
    Labastida-Ramirez, Alejandro
    Rubio-Beltran, Eloisa
    Villalon, Carlos M.
    MaassenVanDenBrink, Antoinette
    CEPHALALGIA, 2019, 39 (03) : 435 - 444
  • [39] CGRP Receptor Antagonism and Migraine
    Edvinsson, Lars
    Ho, Tony W.
    NEUROTHERAPEUTICS, 2010, 7 (02) : 164 - 175
  • [40] Is CGRP a marker for chronic migraine?
    Silberstein, Stephen D.
    Edvinsson, Lars
    NEUROLOGY, 2013, 81 (14) : 1184 - 1185
12345